Oncology Market in India 2025-2029

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	178 Pages	TechNavio	February, 2025	INF19659194

Best Price Guarantee
Price	from $2,500
Length	178 Pages
Publisher	TechNavio
Published Date	February, 2025
SKU	INF19659194

Oncology Market In India 2025-2029

The oncology market in India is forecasted to grow by USD 2018.9 million during 2024-2029, accelerating at a CAGR of 19.8% during the forecast period. The report on the oncology market in India provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increased prevalence of cancer, growing investment for cost-cutting in drug discovery and development, and increasing demand for precision medicine.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's oncology market in India is segmented as below:

By Type

Cancer treatment
Cancer diagnostics

By End-user

Hospitals
Diagnostic laboratories
Diagnostic imaging centers
Others

By Geographical Landscape

Asia

This study identifies the rise in research and development for developing diagnostic devices as one of the prime reasons driving the oncology market in India growth during the next few years. Also, growing adoption of immunotherapy and growing adoption of robotic surgeries in oncology treatments will lead to sizable demand in the market.

The report on the oncology market in India covers the following areas:

Oncology Market in India sizing
Oncology Market in India forecast
Oncology Market in India industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading oncology market in India vendors that include 3M Co., Abbott Laboratories, Alkem Laboratories Ltd., AstraZeneca PLC, Baxter International Inc., Bristol Myers Squibb Co., Cipla Inc., F. Hoffmann La Roche Ltd., GE Healthcare Technologies Inc., Glenmark Pharmaceuticals Ltd., Lupin Ltd., Medtronic PLC, Merck and Co. Inc., Natco Pharma Ltd., Novartis AG, Poly Medicure Ltd., Siemens Healthineers AG, Sun Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., and Zydus Lifesciences Ltd.. Also, the oncology market in India analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Country Market Characteristics; Executive Summary - Chart on Market Segmentation by Type; Executive Summary - Chart on Market Segmentation by End-user; Executive Summary - Chart on Market Segmentation by Disease Type; Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis: 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; 2.2 Criticality of inputs and Factors of differentiation; Overview on criticality of inputs and factors of differentiation; 2.3 Factors of disruption; Overview on factors of disruption; 2.4 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029
3 Market Landscape: 3.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 3.2 Market characteristics; Market characteristics analysis; 3.3 Value chain analysis; Value chain analysis
4 Market Sizing: 4.1 Market definition; Offerings of companies included in the market definition; 4.2 Market segment analysis; Market segments; 4.3 Market size 2024; 4.4 Market outlook: Forecast for 2024-2029; Chart on India - Market size and forecast 2024-2029 ($ million); Data Table on India - Market size and forecast 2024-2029 ($ million); Chart on India: Year-over-year growth 2024-2029 (%); Data Table on India: Year-over-year growth 2024-2029 (%)
5 Historic Market Size: 5.1 Oncology Market in India 2019 - 2023; Historic Market Size - Data Table on Oncology Market in India 2019 - 2023 ($ million); 5.2 Type segment analysis 2019 - 2023; Historic Market Size - Type Segment 2019 - 2023 ($ million); 5.3 End-user segment analysis 2019 - 2023; Historic Market Size - End-user Segment 2019 - 2023 ($ million); 5.4 Disease Type segment analysis 2019 - 2023; Historic Market Size - Disease Type Segment 2019 - 2023 ($ million)
6 Qualitative Analysis: 6.1 Impact of AI in oncology market in India
7 Five Forces Analysis: 7.1 Five forces summary; Five forces analysis - Comparison between 2024 and 2029; 7.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2024 and 2029; 7.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2024 and 2029; 7.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2024 and 2029; 7.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2024 and 2029; 7.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2024 and 2029; 7.7 Market condition; Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Type: 8.1 Market segments; Chart on Type - Market share 2024-2029 (%); Data Table on Type - Market share 2024-2029 (%); 8.2 Comparison by Type; Chart on Comparison by Type; Data Table on Comparison by Type; 8.3 Cancer treatment - Market size and forecast 2024-2029; Chart on Cancer treatment - Market size and forecast 2024-2029 ($ million); Data Table on Cancer treatment - Market size and forecast 2024-2029 ($ million); Chart on Cancer treatment - Year-over-year growth 2024-2029 (%); Data Table on Cancer treatment - Year-over-year growth 2024-2029 (%); 8.4 Cancer diagnostics - Market size and forecast 2024-2029; Chart on Cancer diagnostics - Market size and forecast 2024-2029 ($ million); Data Table on Cancer diagnostics - Market size and forecast 2024-2029 ($ million); Chart on Cancer diagnostics - Year-over-year growth 2024-2029 (%); Data Table on Cancer diagnostics - Year-over-year growth 2024-2029 (%); 8.5 Market opportunity by Type; Market opportunity by Type ($ million); Data Table on Market opportunity by Type ($ million)
9 Market Segmentation by End-user: 9.1 Market segments; Chart on End-user - Market share 2024-2029 (%); Data Table on End-user - Market share 2024-2029 (%); 9.2 Comparison by End-user; Chart on Comparison by End-user; Data Table on Comparison by End-user; 9.3 Hospitals - Market size and forecast 2024-2029; Chart on Hospitals - Market size and forecast 2024-2029 ($ million); Data Table on Hospitals - Market size and forecast 2024-2029 ($ million); Chart on Hospitals - Year-over-year growth 2024-2029 (%); Data Table on Hospitals - Year-over-year growth 2024-2029 (%); 9.4 Diagnostic laboratories - Market size and forecast 2024-2029; Chart on Diagnostic laboratories - Market size and forecast 2024-2029 ($ million); Data Table on Diagnostic laboratories - Market size and forecast 2024-2029 ($ million); Chart on Diagnostic laboratories - Year-over-year growth 2024-2029 (%); Data Table on Diagnostic laboratories - Year-over-year growth 2024-2029 (%); 9.5 Diagnostic imaging centers - Market size and forecast 2024-2029; Chart on Diagnostic imaging centers - Market size and forecast 2024-2029 ($ million); Data Table on Diagnostic imaging centers - Market size and forecast 2024-2029 ($ million); Chart on Diagnostic imaging centers - Year-over-year growth 2024-2029 (%); Data Table on Diagnostic imaging centers - Year-over-year growth 2024-2029 (%); 9.6 Others - Market size and forecast 2024-2029; Chart on Others - Market size and forecast 2024-2029 ($ million); Data Table on Others - Market size and forecast 2024-2029 ($ million); Chart on Others - Year-over-year growth 2024-2029 (%); Data Table on Others - Year-over-year growth 2024-2029 (%); 9.7 Market opportunity by End-user; Market opportunity by End-user ($ million); Data Table on Market opportunity by End-user ($ million)
10 Market Segmentation by Disease Type: 10.1 Market segments; Chart on Disease Type - Market share 2024-2029 (%); Data Table on Disease Type - Market share 2024-2029 (%); 10.2 Comparison by Disease Type; Chart on Comparison by Disease Type; Data Table on Comparison by Disease Type; 10.3 Breast cancer - Market size and forecast 2024-2029; Chart on Breast cancer - Market size and forecast 2024-2029 ($ million); Data Table on Breast cancer - Market size and forecast 2024-2029 ($ million); Chart on Breast cancer - Year-over-year growth 2024-2029 (%); Data Table on Breast cancer - Year-over-year growth 2024-2029 (%); 10.4 Lung cancer - Market size and forecast 2024-2029; Chart on Lung cancer - Market size and forecast 2024-2029 ($ million); Data Table on Lung cancer - Market size and forecast 2024-2029 ($ million); Chart on Lung cancer - Year-over-year growth 2024-2029 (%); Data Table on Lung cancer - Year-over-year growth 2024-2029 (%); 10.5 Blood cancer - Market size and forecast 2024-2029; Chart on Blood cancer - Market size and forecast 2024-2029 ($ million); Data Table on Blood cancer - Market size and forecast 2024-2029 ($ million); Chart on Blood cancer - Year-over-year growth 2024-2029 (%); Data Table on Blood cancer - Year-over-year growth 2024-2029 (%); 10.6 Colorectal cancer - Market size and forecast 2024-2029; Chart on Colorectal cancer - Market size and forecast 2024-2029 ($ million); Data Table on Colorectal cancer - Market size and forecast 2024-2029 ($ million); Chart on Colorectal cancer - Year-over-year growth 2024-2029 (%); Data Table on Colorectal cancer - Year-over-year growth 2024-2029 (%); 10.7 Others - Market size and forecast 2024-2029; Chart on Others - Market size and forecast 2024-2029 ($ million); Data Table on Others - Market size and forecast 2024-2029 ($ million); Chart on Others - Year-over-year growth 2024-2029 (%); Data Table on Others - Year-over-year growth 2024-2029 (%); 10.8 Market opportunity by Disease Type; Market opportunity by Disease Type ($ million); Data Table on Market opportunity by Disease Type ($ million)
11 Customer Landscape: 11.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Drivers, Challenges, and Opportunity/Restraints: 12.1 Market drivers; 12.2 Market challenges; 12.3 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029; 12.4 Market opportunities/restraints
13 Competitive Landscape: 13.1 Overview; 13.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 13.3 Landscape disruption; Overview on factors of disruption; 13.4 Industry risks; Impact of key risks on business
14 Competitive Analysis: 14.1 Companies profiled; Companies covered; 14.2 Company ranking index; Company ranking index; 14.3 Market positioning of companies; Matrix on companies position and classification; 14.4 Abbott Laboratories; Abbott Laboratories - Overview; Abbott Laboratories - Business segments; Abbott Laboratories - Key news; Abbott Laboratories - Key offerings; Abbott Laboratories - Segment focus; SWOT; 14.5 Alkem Laboratories Ltd.; Alkem Laboratories Ltd. - Overview; Alkem Laboratories Ltd. - Business segments; Alkem Laboratories Ltd. - Key offerings; Alkem Laboratories Ltd. - Segment focus; SWOT; 14.6 AstraZeneca Plc; AstraZeneca Plc - Overview; AstraZeneca Plc - Product / Service; AstraZeneca Plc - Key news; AstraZeneca Plc - Key offerings; SWOT; 14.7 Bristol Myers Squibb Co.; Bristol Myers Squibb Co. - Overview; Bristol Myers Squibb Co. - Product / Service; Bristol Myers Squibb Co. - Key news; Bristol Myers Squibb Co. - Key offerings; SWOT; 14.8 Cipla Inc.; Cipla Inc. - Overview; Cipla Inc. - Business segments; Cipla Inc. - Key news; Cipla Inc. - Key offerings; Cipla Inc. - Segment focus; SWOT; 14.9 F. Hoffmann La Roche Ltd.; F. Hoffmann La Roche Ltd. - Overview; F. Hoffmann La Roche Ltd. - Business segments; F. Hoffmann La Roche Ltd. - Key news; F. Hoffmann La Roche Ltd. - Key offerings; F. Hoffmann La Roche Ltd. - Segment focus; SWOT; 14.10 GE Healthcare Technologies Inc.; GE Healthcare Technologies Inc. - Overview; GE Healthcare Technologies Inc. - Business segments; GE Healthcare Technologies Inc. - Key news; GE Healthcare Technologies Inc. - Key offerings; GE Healthcare Technologies Inc. - Segment focus; SWOT; 14.11 Glenmark Pharmaceuticals Ltd.; Glenmark Pharmaceuticals Ltd. - Overview; Glenmark Pharmaceuticals Ltd. - Product / Service; Glenmark Pharmaceuticals Ltd. - Key offerings; SWOT; 14.12 Lupin Ltd.; Lupin Ltd. - Overview; Lupin Ltd. - Business segments; Lupin Ltd. - Key news; Lupin Ltd. - Key offerings; Lupin Ltd. - Segment focus; SWOT; 14.13 Medtronic Plc; Medtronic Plc - Overview; Medtronic Plc - Business segments; Medtronic Plc - Key news; Medtronic Plc - Key offerings; Medtronic Plc - Segment focus; SWOT; 14.14 Merck and Co. Inc.; Merck and Co. Inc. - Overview; Merck and Co. Inc. - Business segments; Merck and Co. Inc. - Key news; Merck and Co. Inc. - Key offerings; Merck and Co. Inc. - Segment focus; SWOT; 14.15 Natco Pharma Ltd.; Natco Pharma Ltd. - Overview; Natco Pharma Ltd. - Product / Service; Natco Pharma Ltd. - Key offerings; SWOT; 14.16 Siemens Healthineers AG; Siemens Healthineers AG - Overview; Siemens Healthineers AG - Business segments; Siemens Healthineers AG - Key news; Siemens Healthineers AG - Key offerings; Siemens Healthineers AG - Segment focus; SWOT; 14.17 Sun Pharmaceutical Industries Ltd.; Sun Pharmaceutical Industries Ltd. - Overview; Sun Pharmaceutical Industries Ltd. - Product / Service; Sun Pharmaceutical Industries Ltd. - Key news; Sun Pharmaceutical Industries Ltd. - Key offerings; SWOT; 14.18 Zydus Lifesciences Ltd.; Zydus Lifesciences Ltd. - Overview; Zydus Lifesciences Ltd. - Business segments; Zydus Lifesciences Ltd. - Key news; Zydus Lifesciences Ltd. - Key offerings; Zydus Lifesciences Ltd. - Segment focus; SWOT
15 Appendix: 15.1 Scope of the report; 15.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 15.3 Currency conversion rates for US$; Currency conversion rates for US$; 15.4 Research methodology; Research methodology; 15.5 Data procurement; Information sources; 15.6 Data validation; Data validation; 15.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 15.8 Data synthesis; Data synthesis; 15.9 360 degree market analysis; 360 degree market analysis; 15.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Country Market Characteristics; Exhibits4: Executive Summary - Chart on Market Segmentation by Type; Exhibits5: Executive Summary - Chart on Market Segmentation by End-user; Exhibits6: Executive Summary - Chart on Market Segmentation by Disease Type; Exhibits7: Executive Summary - Chart on Company Market Positioning; Exhibits8: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits9: Overview on criticality of inputs and factors of differentiation; Exhibits10: Overview on factors of disruption; Exhibits11: Impact of drivers and challenges in 2024 and 2029; Exhibits12: Parent Market; Exhibits13: Data Table on - Parent Market; Exhibits14: Market characteristics analysis; Exhibits15: Value chain analysis; Exhibits16: Offerings of companies included in the market definition; Exhibits17: Market segments; Exhibits18: Chart on India - Market size and forecast 2024-2029 ($ million); Exhibits19: Data Table on India - Market size and forecast 2024-2029 ($ million); Exhibits20: Chart on India: Year-over-year growth 2024-2029 (%); Exhibits21: Data Table on India: Year-over-year growth 2024-2029 (%); Exhibits22: Historic Market Size - Data Table on Oncology Market in India 2019 - 2023 ($ million); Exhibits23: Historic Market Size - Type Segment 2019 - 2023 ($ million); Exhibits24: Historic Market Size - End-user Segment 2019 - 2023 ($ million); Exhibits25: Historic Market Size - Disease Type Segment 2019 - 2023 ($ million); Exhibits26: Five forces analysis - Comparison between 2024 and 2029; Exhibits27: Bargaining power of buyers - Impact of key factors 2024 and 2029; Exhibits28: Bargaining power of suppliers - Impact of key factors in 2024 and 2029; Exhibits29: Threat of new entrants - Impact of key factors in 2024 and 2029; Exhibits30: Threat of substitutes - Impact of key factors in 2024 and 2029; Exhibits31: Threat of rivalry - Impact of key factors in 2024 and 2029; Exhibits32: Chart on Market condition - Five forces 2024 and 2029; Exhibits33: Chart on Type - Market share 2024-2029 (%); Exhibits34: Data Table on Type - Market share 2024-2029 (%); Exhibits35: Chart on Comparison by Type; Exhibits36: Data Table on Comparison by Type; Exhibits37: Chart on Cancer treatment - Market size and forecast 2024-2029 ($ million); Exhibits38: Data Table on Cancer treatment - Market size and forecast 2024-2029 ($ million); Exhibits39: Chart on Cancer treatment - Year-over-year growth 2024-2029 (%); Exhibits40: Data Table on Cancer treatment - Year-over-year growth 2024-2029 (%); Exhibits41: Chart on Cancer diagnostics - Market size and forecast 2024-2029 ($ million); Exhibits42: Data Table on Cancer diagnostics - Market size and forecast 2024-2029 ($ million); Exhibits43: Chart on Cancer diagnostics - Year-over-year growth 2024-2029 (%); Exhibits44: Data Table on Cancer diagnostics - Year-over-year growth 2024-2029 (%); Exhibits45: Market opportunity by Type ($ million); Exhibits46: Data Table on Market opportunity by Type ($ million); Exhibits47: Chart on End-user - Market share 2024-2029 (%); Exhibits48: Data Table on End-user - Market share 2024-2029 (%); Exhibits49: Chart on Comparison by End-user; Exhibits50: Data Table on Comparison by End-user; Exhibits51: Chart on Hospitals - Market size and forecast 2024-2029 ($ million); Exhibits52: Data Table on Hospitals - Market size and forecast 2024-2029 ($ million); Exhibits53: Chart on Hospitals - Year-over-year growth 2024-2029 (%); Exhibits54: Data Table on Hospitals - Year-over-year growth 2024-2029 (%); Exhibits55: Chart on Diagnostic laboratories - Market size and forecast 2024-2029 ($ million); Exhibits56: Data Table on Diagnostic laboratories - Market size and forecast 2024-2029 ($ million); Exhibits57: Chart on Diagnostic laboratories - Year-over-year growth 2024-2029 (%); Exhibits58: Data Table on Diagnostic laboratories - Year-over-year growth 2024-2029 (%); Exhibits59: Chart on Diagnostic imaging centers - Market size and forecast 2024-2029 ($ million); Exhibits60: Data Table on Diagnostic imaging centers - Market size and forecast 2024-2029 ($ million); Exhibits61: Chart on Diagnostic imaging centers - Year-over-year growth 2024-2029 (%); Exhibits62: Data Table on Diagnostic imaging centers - Year-over-year growth 2024-2029 (%); Exhibits63: Chart on Others - Market size and forecast 2024-2029 ($ million); Exhibits64: Data Table on Others - Market size and forecast 2024-2029 ($ million); Exhibits65: Chart on Others - Year-over-year growth 2024-2029 (%); Exhibits66: Data Table on Others - Year-over-year growth 2024-2029 (%); Exhibits67: Market opportunity by End-user ($ million); Exhibits68: Data Table on Market opportunity by End-user ($ million); Exhibits69: Chart on Disease Type - Market share 2024-2029 (%); Exhibits70: Data Table on Disease Type - Market share 2024-2029 (%); Exhibits71: Chart on Comparison by Disease Type; Exhibits72: Data Table on Comparison by Disease Type; Exhibits73: Chart on Breast cancer - Market size and forecast 2024-2029 ($ million); Exhibits74: Data Table on Breast cancer - Market size and forecast 2024-2029 ($ million); Exhibits75: Chart on Breast cancer - Year-over-year growth 2024-2029 (%); Exhibits76: Data Table on Breast cancer - Year-over-year growth 2024-2029 (%); Exhibits77: Chart on Lung cancer - Market size and forecast 2024-2029 ($ million); Exhibits78: Data Table on Lung cancer - Market size and forecast 2024-2029 ($ million); Exhibits79: Chart on Lung cancer - Year-over-year growth 2024-2029 (%); Exhibits80: Data Table on Lung cancer - Year-over-year growth 2024-2029 (%); Exhibits81: Chart on Blood cancer - Market size and forecast 2024-2029 ($ million); Exhibits82: Data Table on Blood cancer - Market size and forecast 2024-2029 ($ million); Exhibits83: Chart on Blood cancer - Year-over-year growth 2024-2029 (%); Exhibits84: Data Table on Blood cancer - Year-over-year growth 2024-2029 (%); Exhibits85: Chart on Colorectal cancer - Market size and forecast 2024-2029 ($ million); Exhibits86: Data Table on Colorectal cancer - Market size and forecast 2024-2029 ($ million); Exhibits87: Chart on Colorectal cancer - Year-over-year growth 2024-2029 (%); Exhibits88: Data Table on Colorectal cancer - Year-over-year growth 2024-2029 (%); Exhibits89: Chart on Others - Market size and forecast 2024-2029 ($ million); Exhibits90: Data Table on Others - Market size and forecast 2024-2029 ($ million); Exhibits91: Chart on Others - Year-over-year growth 2024-2029 (%); Exhibits92: Data Table on Others - Year-over-year growth 2024-2029 (%); Exhibits93: Market opportunity by Disease Type ($ million); Exhibits94: Data Table on Market opportunity by Disease Type ($ million); Exhibits95: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits96: Impact of drivers and challenges in 2024 and 2029; Exhibits97: Overview on criticality of inputs and factors of differentiation; Exhibits98: Overview on factors of disruption; Exhibits99: Impact of key risks on business; Exhibits100: Companies covered; Exhibits101: Company ranking index; Exhibits102: Matrix on companies position and classification; Exhibits103: Abbott Laboratories - Overview; Exhibits104: Abbott Laboratories - Business segments; Exhibits105: Abbott Laboratories - Key news; Exhibits106: Abbott Laboratories - Key offerings; Exhibits107: Abbott Laboratories - Segment focus; Exhibits108: SWOT; Exhibits109: Alkem Laboratories Ltd. - Overview; Exhibits110: Alkem Laboratories Ltd. - Business segments; Exhibits111: Alkem Laboratories Ltd. - Key offerings; Exhibits112: Alkem Laboratories Ltd. - Segment focus; Exhibits113: SWOT; Exhibits114: AstraZeneca Plc - Overview; Exhibits115: AstraZeneca Plc - Product / Service; Exhibits116: AstraZeneca Plc - Key news; Exhibits117: AstraZeneca Plc - Key offerings; Exhibits118: SWOT; Exhibits119: Bristol Myers Squibb Co. - Overview; Exhibits120: Bristol Myers Squibb Co. - Product / Service; Exhibits121: Bristol Myers Squibb Co. - Key news; Exhibits122: Bristol Myers Squibb Co. - Key offerings; Exhibits123: SWOT; Exhibits124: Cipla Inc. - Overview; Exhibits125: Cipla Inc. - Business segments; Exhibits126: Cipla Inc. - Key news; Exhibits127: Cipla Inc. - Key offerings; Exhibits128: Cipla Inc. - Segment focus; Exhibits129: SWOT; Exhibits130: F. Hoffmann La Roche Ltd. - Overview; Exhibits131: F. Hoffmann La Roche Ltd. - Business segments; Exhibits132: F. Hoffmann La Roche Ltd. - Key news; Exhibits133: F. Hoffmann La Roche Ltd. - Key offerings; Exhibits134: F. Hoffmann La Roche Ltd. - Segment focus; Exhibits135: SWOT; Exhibits136: GE Healthcare Technologies Inc. - Overview; Exhibits137: GE Healthcare Technologies Inc. - Business segments; Exhibits138: GE Healthcare Technologies Inc. - Key news; Exhibits139: GE Healthcare Technologies Inc. - Key offerings; Exhibits140: GE Healthcare Technologies Inc. - Segment focus; Exhibits141: SWOT; Exhibits142: Glenmark Pharmaceuticals Ltd. - Overview; Exhibits143: Glenmark Pharmaceuticals Ltd. - Product / Service; Exhibits144: Glenmark Pharmaceuticals Ltd. - Key offerings; Exhibits145: SWOT; Exhibits146: Lupin Ltd. - Overview; Exhibits147: Lupin Ltd. - Business segments; Exhibits148: Lupin Ltd. - Key news; Exhibits149: Lupin Ltd. - Key offerings; Exhibits150: Lupin Ltd. - Segment focus; Exhibits151: SWOT; Exhibits152: Medtronic Plc - Overview; Exhibits153: Medtronic Plc - Business segments; Exhibits154: Medtronic Plc - Key news; Exhibits155: Medtronic Plc - Key offerings; Exhibits156: Medtronic Plc - Segment focus; Exhibits157: SWOT; Exhibits158: Merck and Co. Inc. - Overview; Exhibits159: Merck and Co. Inc. - Business segments; Exhibits160: Merck and Co. Inc. - Key news; Exhibits161: Merck and Co. Inc. - Key offerings; Exhibits162: Merck and Co. Inc. - Segment focus; Exhibits163: SWOT; Exhibits164: Natco Pharma Ltd. - Overview; Exhibits165: Natco Pharma Ltd. - Product / Service; Exhibits166: Natco Pharma Ltd. - Key offerings; Exhibits167: SWOT; Exhibits168: Siemens Healthineers AG - Overview; Exhibits169: Siemens Healthineers AG - Business segments; Exhibits170: Siemens Healthineers AG - Key news; Exhibits171: Siemens Healthineers AG - Key offerings; Exhibits172: Siemens Healthineers AG - Segment focus; Exhibits173: SWOT; Exhibits174: Sun Pharmaceutical Industries Ltd. - Overview; Exhibits175: Sun Pharmaceutical Industries Ltd. - Product / Service; Exhibits176: Sun Pharmaceutical Industries Ltd. - Key news; Exhibits177: Sun Pharmaceutical Industries Ltd. - Key offerings; Exhibits178: SWOT; Exhibits179: Zydus Lifesciences Ltd. - Overview; Exhibits180: Zydus Lifesciences Ltd. - Business segments; Exhibits181: Zydus Lifesciences Ltd. - Key news; Exhibits182: Zydus Lifesciences Ltd. - Key offerings; Exhibits183: Zydus Lifesciences Ltd. - Segment focus; Exhibits184: SWOT; Exhibits185: Inclusions checklist; Exhibits186: Exclusions checklist; Exhibits187: Currency conversion rates for US$; Exhibits188: Research methodology; Exhibits189: Information sources; Exhibits190: Data validation; Exhibits191: Validation techniques employed for market sizing; Exhibits192: Data synthesis; Exhibits193: 360 degree market analysis; Exhibits194: List of abbreviations